This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of childhood migraine

Authoring team

  • assessment of headache and diagnosis of migraine
  • initial management should address any underlying concerns of the child and parents/carers
  • self-help strategies may help in the prevention of attacks e.g. minimising or avoiding stress, having regular bedtimes and mealtimes and sufficient (not excessive) sleep
  • behavioural interventions such as thermal biofeedback and progressive muscle relaxation - these interventions may help but this needs confirmation with appropriate studies
  • acute treatment of migraine
    • for the acute treatment of headaches then paracetamol or ibuprofen is usually sufficient, combined with an antiemetics (e.g. domperidone) if vomiting is a problem
    • evidence relating to the use of nasal sumatriptan at the licensed dose to relieve migraine in those aged 12-17 years is weak (1)
  • prohylaxis
    • with respect to migraine prophylaxis in children a review states (2):
      • propranolol was found to be possibly effective in reducing migraine frequency by 50% compared with placebo
      • topiramate and cinnarizine (not available in the US or Canada) were possibly associated with reduced frequency of headache compared with placebo

Reference:

  1. Drug and Therapeutics Bulletin (2004), 42 (4), 25-8.
  2. Hovaguimian A, Roth J. Management of chronic migraine BMJ 2022; 379 :e067670 doi:10.1136/bmj-2021-067670

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.